In a Phase 2 clinical trial, CJC-1295 produced dose-dependent increases in growth hormone and IGF-1 levels in healthy adults aged 21 to 61
Audrey Miklius, a Dallas endocrinologist
Retatrutide 5mg Dosing & Observed Effects in Research In research settings, retatrutide is typically studied at doses between 1 mg and 12 mg , usually given once a week through subcutaneous injections
The obesity segment is the fastest-growing segment in the market, driven by the increasing awareness of dietary changes, increased physical activity, and weight management
En la primera mitad del estudio, el equipo de Drucker observ que el frmaco GLP-1 reduca la placa en las arterias, pero la presencia o la falta del receptor GLP-1 en los vasos sanguneos y las clulas inmunitarias de la aorta no influan